Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2013 by Gruppo Italiano Studio Linfomi
Sponsor:
Information provided by (Responsible Party):
Gruppo Italiano Studio Linfomi
ClinicalTrials.gov Identifier:
NCT01686386
First received: July 31, 2012
Last updated: April 4, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)